Tim Guo

Company: GentiBio

Job title: Principal Scientist

Seminars:

Robust immune evasion technology to enable persistence of allogeneic cell therapies 2:00 pm

Overcoming host rejection is critical for the success of allogeneic cell therapies Common approaches in the field to mitigate rejection will be discussed GentiBio’s proprietary immune evasion engineering enables durable persistence of allogeneic cells in preclinical modelsRead more

day: Day Two Track A Afternoon